|
Last Updated: 05/24/2007
Requests for Application (RFA) are usually announced with special application
dates; there is no possibility for applying after that date. Program
Announcements (PA, PAR) may be open for a set period of time, such as 3 years
or less; applications submitted in response to Program Announcements may be due
on the standard dates (February 1, June1, and October 1) or may have special
dates for receipt of applications. Please pay attention to these dates.
Contact a CIP staff member if you have questions.
For information on funding opportunities that are now closed, go to
Current Funding Opportunities.
 |
 |
 |
 |
| Past Funding Opportunities |
 |
 |
 |
 COLLABORATIVE RESEARCH TO EXPLORE NEW USES FOR EXISTING RADIOLIGANDS (NIDA, NIA, NIMH, NINDS) (R21/R33) (RFA-DA-08-001) |
 |
 |
 SHARING DATA AND TOOLS: FEDERATION USING THE BIRN AND caBIG INFRASTRUCTURES (MULTIPLE INSTITUTES) (R01) (PAR-07-426) |
 |
 |
 LYMPHATIC BIOLOGY IN HEALTH AND DISEASE (R01) (NCI, NHLBI, NICHD, NIDDK, NINR) (PAR-07-420) |
 |
 |
 High-end Instrumentation Grant Program (S10) (NCRR) (PAR-07-383) |
 |
 |
 Biology of Breast Pre-Malignancies (R01) (NCI) (RFA-CA-07-047) |
 |
 |
 INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD (U54) (ROADMAP) (RFA-RM-07-007) |
 |
 |
 INNOVATIONS IN BIOMEDICAL COMPUTATIONAL SCIENCE AND TECHNOLOGY (MULTIPLE ICS)(R01) (PAR-07-344) |
 |
 |
 PAR-07-235: Continued Development and Maintenance of Software (R01) (Multiple ICs) |
 |
 |
 Nanoscience and Nanotechnology in Biology and Medicine (R01: PAR-07-270); (R21: PAR-07-271) |
 |
 |
 Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01) (NIDDK, NIBIB, NIAAA) (PA-07-258) |
 |
 |
 PA-07-260 & PA-06-281: Understanding the effects of emerging cellular, molecular, and genomic technologies on cancer health care delivery (R01) & (R21) (NCI) |
 |
 |
 Ancillary Studies to the AD Neuroimaging Initiative (R01) (NIA, NIBIB) (PA-07-134) |
 |
 |
 Innovations in Biomedical Computational Science and Technology Initiative (SBIR [R43/R44]) (PAR-07-160) Innovations in Biomedical Computational Science and Technology Initiative (STTR [R41/R42]) (PAR-07-161) |
 |
 |
 Shared Instrumentation Grant Program (S10) (NCRR) (PAR-07-105) |
 |
 |
 PA-06-533: Functional Links between the Immune System, Brain Function and Behavior (R21) (NIMH, NCI, NIA, NIAMS, NIBIB, NIDA, NINDS) |
 |
 |
 PAR-06-540: Cancer Education Grants Program (R25) |
 |
 |
 PA-06-512: Mentored Clinical Scientist Research Career Development Award (K08) |
 |
 |
 NOT-FD-06-001: Notice of Availability of Funds to Support Clinical trials on the Safety and Effectiveness of Products for Rare Diseases (FDA) |
 |
 |
 PA-06-461, PA-06-462, & PA-06-463: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21, R33, & R21/R33) (NIMH, NIA, NIAAA, NIBIB, NIDA, NINDS) |
 |
 |
 PAR-06-475: Nanoscience and Nanotechnology in Biology and Medicine(R21) (Multiple ICs) |
 |
 |
 NOT-OD-06-081: NIH Offers Commercialization Assistance Program to SBIR Phase II Awardees |
 |
 |
 PAR-06-459: Bioengineering Research Partnerships (BRP) [R01] |
 |
 |
 PAR-06-455: The NCI Transition Career Development Award (K22) |
 |
 |
 PAR-06-411: Exploratory Innovations in Biomedical Computational Science and Technology (R21) |
 |
 |
 PA-06-468: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) |
 |
 |
 PA-06-419: Bioengineering Research Grants (BRG) [R01] |
 |
 |
 RFA-CA-06-014: Tumor Microenvironment Network (TMEN) (U54) |
 |
 |
 Interdisciplinary Research Consortium (U54) Preapplication for Interdisciplinary Research Consortium (X02) |
 |
 |
 RFA-RM-06-007: Nanomedicine Development Centers (PN2) |
 |
 |
 PA-06-149: Innovative and Exploratory Research in Digestive Diseases and Nutrition (R21) (NIDDK, NCI, ODS) |
 |
 |
 PAR-06-313: Cancer prevention research small grant program (R03) (NCI) |
 |
 |
 PA-06-314: Pilot Studies in Pancreatic Cancer (R03) (NCI) |
 |
 |
 PAR-06-311: Imaging - science track award for research transition (I/START) (R03) (NIDA) |
 |
 |
 PA-06-299: Exploratory studies in cancer detection, diagnosis, and prognosis (R21) |
 |
 |
 RFA-AI-06-030: Radionuclide decorporation agents for radiation/nuclear emergencies: project bioshield (R01) (NIAID) |
 |
 |
 PA-06-295: Etiology, prevention, and treatment of hepatocellular carcinoma (R21) (NCI, NIAAA, NIBIB, NIDDK) |
 |
 |
 PA-06-278: Neurotechnology research, development, and enhancement (R21) (NIMH, NIA, NIBIB, NICHD, NIDA, NIDCD, NINDS) |
 |
 |
 PAR-05-122: Development of PET and SPECT Ligands for Brain Imaging (SBIR/STTR AWARD) |
 |
 |
 NIH RFA-RM-04-022 National Centers for Biomedical Computing |
 |
 |
 Japan Society Fellowships |
 |
 |
 PAR-05-063: Collaborations with National Centers for Biomedical Computing |
 |
 |
 PA-05-143: Mentored Patient-Oriented Research Career Development Award (K23) |
 |
 |
 RR-05-001: Technology Development for Biomedical Applications (NCRR) |
 |
 |
 PAR-05-145: Established Investigator Award In Cancer Prevention & Control (NCI) |
 |
 |
 PAR-05-124: High-End Instrumentation Grant Program (NCRR) |
 |
 |
 PA-05-116: Pilot Studies in Pancreatic Cancer (NCI) |
 |
 |
 NIH RFA-RM-05-008 Regional Translational Research Center Planning Grants |
 |
 |
 NIH RFA-RM-05-008 Regional Translational Research Center Planning Grants |
 |
 |
 NIH RFA-RM-04-022 National Centers for Biomedical Computing |
 |
 |
 PAR-04-155: Exploratory/Developmental Grants for Quick-Trials for Novel Cancer Therapies (R21) |
 |
 |
 PA-04-047: Competing Continuation SBIR/STTR PHASE II Grants for Cancer Diagnosis, Prevention and Treatment |
 |
 |
 RFA: CA-05-002: Innovative Technologies for Molecular Analysis of Cancer |
 |
 |
 RFA: CA-05-003: Application of Emerging Technologies for Cancer Research |
 |
 |
 NIH PAR-04-023: Bioengineering Research Partnership Programs |
 |
 |
 BAA: N01-CO-47010-16: Novel Technologies for Noninvasive Detection, Diagnosis and Treatment of Cancer |
 |
 |
 NIH-PAR-06-075: Nanoscience and Nanotechnology in Biology and Medicine |
 |
 |
 NCI RFA: Mouse Models of Human Cancers Consortium: U01: RFA: CA-04-002 |
 |
 |
 PAR-03-005: Exploratory/Developmental Grants for Quick-Trials for Novel Cancer Therapies: (R21) |
 |
 |
 BAA: N01-CO-27031-16 Novel Technologies for Noninvasive Detection, Diagnosis and Treatment of Cancer |
 |
 |
 NCI PA: Innovative Technologies for the Molecular Analysis of Cancer: Phase Innovation Award (R21/R33)/ SBIR/STTR (PAR-01-105): Reissue |
 |
 |
 NCI PA: Applications of Innovative Technologies for the Molecular Analysis of Cancer: Phased Technology Application Award (R21/33)/SBIR/STTR (PAR-01-107): Reissue |
 |
 |
 NIH OD-00-016: Nanoscience and Nanotechnology Grant Applications |
 |
 |
 NCRR Shared Instrumentation Grant |
 |
 |
 NLM Visible Human Project Image Processing Tools |
 |
 |
 NIH PA-98-092: Shared Resources for Scientists Outside NCI Cancer Centers |
 |
 |
 NIH PA-98-094: Cerebral Radiobiology and Neuro-imaging of Brain Tumors |
 |
 |
|